The Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Evacetrapib Administered as Monotherapy or in Combination With Statins
Evacetrapib is a novel cholesteryl ester transfer protein (CETP) inhibitor currently being evaluated in a late-stage cardiovascular outcome trial. Using population-based models, we analyzed evacetrapib concentration data along with high-density lipoprotein cholesterol (HDL-C) and low-density lipopro...
Main Authors: | Friedrich, S, Kastelein, J J P, James, D, Waterhouse, T, Nissen, S E, Nicholls, S J, Krueger, K A |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910017/ |
Similar Items
-
Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapib
by: Small, David S., et al.
Published: (2016) -
Impact of Increased Gastric pH on the Pharmacokinetics of Evacetrapib in Healthy Subjects
by: Small, David S., et al.
Published: (2016) -
Population Pharmacokinetics and Pharmacodynamics of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy
by: Le, KN, et al.
Published: (2015) -
Evaluation of the pharmacokinetics and pharmacodynamics of ticagrelor co-administered with aspirin in healthy volunteers
by: Teng, Renli, et al.
Published: (2013) -
The Pharmacokinetics and Pharmacodynamics of Iron Preparations
by: Geisser, Peter, et al.
Published: (2011)